Mild to moderate pre-eclampsia, second trimester
ICD-10 O14.02 is a billable code used to indicate a diagnosis of mild to moderate pre-eclampsia, second trimester.
Mild to moderate pre-eclampsia is characterized by the onset of hypertension and proteinuria after 20 weeks of gestation. In the second trimester, this condition may present with blood pressure readings of 140/90 mmHg or higher, along with protein levels in the urine exceeding 300 mg in a 24-hour collection. Symptoms may include mild headaches, visual disturbances, and swelling. It is crucial to monitor the mother and fetus closely, as pre-eclampsia can progress to severe pre-eclampsia or eclampsia, which poses significant risks to both. Management typically involves close observation, lifestyle modifications, and possibly the administration of magnesium sulfate to prevent seizures. The condition requires careful documentation of blood pressure readings, proteinuria levels, and any symptoms experienced by the patient to ensure accurate coding and appropriate care.
Documentation must include detailed blood pressure readings, proteinuria results, and any symptoms experienced by the patient.
Patients presenting with elevated blood pressure during routine prenatal visits, or those with a history of hypertension.
Ensure that all clinical findings are documented to support the diagnosis and management plan.
High-risk pregnancy documentation must include comprehensive assessments of maternal and fetal well-being.
Management of patients with a history of pre-eclampsia or those with multiple risk factors.
Close monitoring for signs of progression to severe pre-eclampsia or HELLP syndrome is essential.
Used for routine follow-up visits for patients diagnosed with mild pre-eclampsia.
Document blood pressure readings, proteinuria tests, and any symptoms.
Ensure that the visit is focused on managing pre-eclampsia and monitoring for progression.
Key symptoms include elevated blood pressure, proteinuria, mild headaches, visual disturbances, and swelling. Patients may not exhibit all symptoms, so regular monitoring is essential.
